The recent identification of brown fat stem cells in adult humans may lead to new treatments for heart and endocrine disorders, according to a new University of Utah study published in the journal Stem Cells.
David Classen, M.D., Ph.D., an associate professor of medicine and consultant of infectious diseases at the University of Utah School of Medicine, will be honored in December for a lifetime of achievement related to improving patient safety.
June L. Round, Ph.D., has been named one of the nation's "most innovative young scientists and engineers" in the 2013 Packard Fellowships in Science and Engineering program.
Previous studies have identified links between women’s prepregnancy body mass index (BMI) and pregnancy weight gain to an increased risk for the development of autism spectrum disorders (ASD) in children. But in the new study from University of Utah, researchers build on prior research by identifying an association between autism spectrum disorder risk and prenatal weight gain, after accounting for important related factors such as a woman’s prepregnancy BMI.
For people with a family history of adenomas (colon polyps that lead to colon cancer), up to 10 percent of colorectal cancers could be missed when current national screening guidelines are followed.
The goal of the Sojourn Awards is to promote innovations by inspiring health care workers and to invest in their futures. Holli Martinez will be recognized along with recipients from Idaho, Oregon and Washington who have worked to advance the access, quality and understanding of palliative care.
University of Utah researchers have found that deficiency of an antioxidant response protein called nuclear erythroid-2 like factor-2 (Nrf2) delays or prevents hypertrophic cardiomyopathy.
University of Utah Center for Clinical and Translational Science has been selected to receive a $20.4 million grant from the National Institutes of Health. The grant will allow the Center to provide support for all aspects of translational research over the next five years.
CureSearch for Children’s Cancer this week awarded researchers at Huntsman Cancer Institute at the University of Utah a $1.73 million grant to test a novel targeted treatment for Ewing sarcoma that hopefully will disrupt the cancer’s growth and spread.
Adam Frost, M.D., Ph.D., a professor of biochemistry, and Ryan O’Connell, Ph.D., an assistant professor of pathology, were selected to receive the NIH Director's New Innovator Award from a competitive, national field of researchers.
Craig H. Neilsen exemplified the extraordinary success and quality of life one can achieve after experiencing a life-changing spinal cord injury (SCI).
The University of Utah on Friday, Aug. 23, 2013, broke ground on the $36.4 million Ray and Tye Noorda Oral Health Education Building, which when completed in December 2014 will house the University’s new School of Dentistry.
Chapman, a noted scholar and researcher, will lead the University of Utah's Department of Biomedical Informatics as the school’s new chair effective Sept. 1.
University of Utah and George E. Wahlen Department of Veterans Affairs Medical Center researchers have developed a mathematical model to help answer critical questions and guide the response to an anthrax exposure.
Newly released research findings from University of Utah neuroscientists assert that there is no evidence within brain imaging that indicates some people are right-brained or left-brained.
For years in popular culture, the terms left-brained and right-brained have come to refer to personality types, with an assumption that some people use the right side of their brain more, while some use the left side more.
Following a two-year study, University of Utah researchers have debunked that myth through identifying specific networks in the left and right brain that process lateralized functions.
When a child is diagnosed with cancer, one of the first questions the parents ask is “Will my other children get cancer?” A new study from Huntsman Cancer Institute (HCI) at the University of Utah suggests the answer to that question depends on whether a family history of cancer exists.
The study, formally titled, “Optimal Germinal Center B Cell Activation and T-Dependent Antibody Responses Require Expression of the Mouse Complement Receptor Cr1” used a mouse model system to examine receptors on a select set of cells that centralize antigens in sites of high immune activity, which are substances that cause a person’s immune system to produce antibodies.
Among their discoveries was a finding that cells that are central to organizing the centers for B cells (which are antibody-producing cells) express a receptor called Cr1 when undergoing processes to make antibodies.
Citing his groundbreaking contributions to understanding the evolving role of platelets, the American Society of Hematology (ASH) has awarded University of Utah professor of medicine Andrew S. Weyrich, Ph.D., the 2013 Dameshek Prize.
When U.S. physicians prescribe antibiotics, more than 60 percent of the time they choose some of the strongest types of antibiotics, referred to as “broad spectrum,” which are capable of killing multiple kinds of bacteria, University of Utah researchers show in a new study.
Electroconvulsive therapy (ECT) has long been considered the most effective treatment of medication-resistant depression. But millions of people don’t take advantage of it because of the side effects and misperception of the therapy.
University of Utah professor and chair of neurosurgery, William T. Couldwell, M.D., Ph.D., has been named the 2013-2014 president of the American Association of Neurological Surgeons (AANS).
An internationally regarded researcher and highly honored dental educator, Rena N. D’Souza, D.D.S., M.S., Ph.D., has been selected as the first permanent dean of the University of Utah’s School of Dentistry. She assumes her new role on Aug.1, 2013.
The University of Utah today announced that Patricia G. Morton, R.N., Ph.D. — a nationally known expert in nursing education, critical care and cardiovascular nursing —will lead its College of Nursing as dean.
University of Utah researchers discovered that over the past 10 years children received more solid organ transplants and fewer children died waiting for a life-saving transplant.
Research conducted by the Pelvic Floor Disorders Network, an initiative funded by the National Institutes of Health, has revealed that the long-term success rates of a surgery to treat pelvic organ prolapse are lower than expected.
The Patient-Centered Outcomes Research Institute (PCORI) has approved a $1.9 million research award to the University of Utah to study asthma in children and how better monitoring of the disease could improve health.
While the genes provided by the father arrive at fertilization pre-programmed to the state needed by the embryo, the genes provided by the mother are in a different state and must be reprogrammed to match.
A gene mutation associated with a rare sleep disorder surprisingly also contributes to debilitating migraines, a new discovery that could change the treatment of migraines by allowing development of drugs specifically designed to treat the chronic headaches.
Researchers from Huntsman Cancer Institute (HCI) at the University of Utah have developed a novel and powerful technique to identify the targets for a group of enzymes called RNA cytosine methyltransferases (RMTs) in human RNA.
James Chen-tson Fang, M.D., has been named chief of cardiovascular medicine at the University of Utah School of Medicine and director of the cardiovascular service line at University of Utah Health Care.
Hematologist John Sweetenham, M.D., has been appointed Senior Director of Clinical Affairs and Executive Medical Director at Huntsman Cancer Institute (HCI), and Professor in the Department of Medicine at the University of Utah.
The University of Utah School of Medicine has named 20 physicians and scientists as inaugural fellows in the University of Utah Academy of Medical Science Educators.
The lack of very long chain fatty acids does not cause blindness in children with the incurable eye disease known as Stargardt type 3 retinal degeneration.
Inhibition of the protein known as adenosine diphosphate ribosylation factor 6 (ARF6) reduces the spread of melanoma to the lungs in mice, according to a study published in the March 5 issue of Science Signaling online.
An estimated 300,000 U.S. patients get surgical site infections every year, and while the causes are varied, a new University of Utah study suggests that some who get an infection can blame it partly on their genes.
Geneticists led by University of Utah Nobel Prize Laureate Mario R. Capecchi, Ph.D., have engineered mice that develop clear cell sarcoma (CCS), a significant step in better understanding how this rare and deadly soft tissue cancer arises.
University of Utah (the U) researchers, in collaboration with several groups from around the country, published a paper on Monday, Jan. 14, 2013, following one of the biggest studies of its kind, that extends our understanding of genes related to autism spectrum diseases (ASDs) and advances methods for early detection and treatment.
Researchers have discovered that adding lovastatin, a widely used cholesterol-lowering drug, to traditional antimalarial treatment decreases neuroinflammation and protects against cognitive impairment in a mouse model of cerebral malaria.
As the prescribed use of buprenorphine has dramatically increased in recent years, accidental exposure of children to the drug has risen sharply, placing them at risk for serious injury, and in extremely rare cases even death.
People who reside in rural areas of Utah are less likely to follow colorectal cancer (CRC) screening recommendations than their urban counterparts, according to researchers from Huntsman Cancer Institute (HCI) at the University of Utah.
Health care consumers considering a physician at University of Utah Health Care now have an additional tool— online access to the system’s patient satisfaction scores and comments. The rankings are based on more than 40,000 patient surveys and evaluate physicians on nine questions.
Discovery of a new drug with high potential to treat Ewing sarcoma, an often deadly cancer of children and young adults, and the previously unknown mechanism behind it, come hand-in-hand in a new Huntsman Cancer Institute (HCI) study.
A new discovery concerning a fundamental understanding about how DNA works will produce a “180-degree change in focus” for researchers who study how gene packaging regulates gene activity, including genes that cause cancer and other diseases.
University of Utah medical researchers have identified a way to treat inflammation while potentially minimizing a serious side effect of current medications: the increased risk for infection.
Genetic test results for Lynch syndrome often prove inconclusive, but two new studies show that two-thirds to three-fourths of genetic variants can be classified into categories that indicate the most appropriate screening and treatment guidelines.
Researchers from the University of Utah report that a cell-to-cell communication network known as the Wnt signaling pathway plays an important role in both the production and specialization of nerve cell precursors in the hypothalamus.
For the first time, a mutation in HIF2α, a specific group of genes known as transcription factors that is involved in red blood cell production and cell metabolism, has been identified in cancer tumor cells.
Using advanced computer simulations, University of Utah College of Pharmacy researchers have produced moving images of a protein complex that is an important target for anti-cancer drugs.